Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
-
ACMG Letter Regarding Colorado Senate Bill 133 (2019) – Requesting Amendments
-
ACMG Letter Regarding Texas House Bill 2815 (2019) – Requesting Amendments
-
ACMG Letter Regarding Texas Senate Bill 754 (2019) – Requesting Amendments
-
Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
-
ACMG Letter to Congress Concerning Legislation for Reimbursement of Genetic Counseling Services
-
ACMG Letter to Congress Concerning Legislation for Reimbursement of Genetic Counseling Services
-
ACMG Letter Regarding Pennsylvania House Bills 2618 and 2619 (2018) – Requesting Amendments
-
ACMG Letter Regarding Pennsylvania Senate Bills 1074 and 1169 (2018) – Requesting Amendments
-
ACMG Responds to FDA’s Approval for DTC Testing for Three BRCA Gene Mutations